Recap: Aclaris Therapeutics Q1 Earnings

Aclaris Therapeutics ACRS reported its Q1 earnings results on Tuesday, May 10, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Aclaris Therapeutics beat estimated earnings by 22.5%, reporting an EPS of $-0.31 versus an estimate of $-0.4.

Revenue was down $324.00 thousand from the same period last year.

Last quarter the company missed on EPS by $0.01 which was followed by a 8.64% increase in the share price the next day.

Here's a look at Aclaris Therapeutics's past performance:

Quarter	Q4 2021	Q3 2021	Q2 2021	Q1 2021
EPS Estimate	-0.36	-0.28	-0.29	-0.29
EPS Actual	-0.37	-0.35	-0.34	-0.57
Revenue Estimate	1.79M	1.77M	1.69M	1.69M
Revenue Actual	1.50M	1.66M	1.82M	1.78M

To track all earnings releases for Aclaris Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar